Grunenthal GMBH v. Alkem Labs., Ltd., Appeal Nos. 2017-1153, -2048, -2049, -2050 (Fed. Cir. Mar. 28, 2019) -
This week the Federal Circuit issued a rare decision concerning the utility doctrine in patent law. In general,...more
4/2/2019
/ Computer-Related Inventions ,
Patent Examinations ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Section 101 ,
Section 102 ,
Section 103
University of Florida Research Foundation, Inc. v. General Electric Company, Appeal No. 2018-1284 (Fed. Cir. Feb. 26, 2019) -
The Court this week affirmed the Rule 12(b)(6) dismissal of an infringement lawsuit, finding...more
3/6/2019
/ Abstract Ideas ,
Appeals ,
Dismissals ,
Federal Rule 12(b)(6) ,
Patent Infringement ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Section 101 ,
Sovereign Immunity ,
Subject Matter Jurisdiction
PATENT CASE OF THE WEEK -
Athena Diagnostics, Inc. v. Mayo Collaborative Services, LLC, Appeal No. 2017-2508 (Fed. Cir. Feb. 6, 2019)
In an appeal from an order of the United States District Court for the District of...more
2/12/2019
/ Appeals ,
Article III ,
Claim Construction ,
Google ,
Internet Service Providers (ISPs) ,
Mootness ,
Patent Infringement ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Section 101 ,
Venue
PATENT CASE OF THE WEEK -
Data Engine Technologies, LLC v. Google LLC, Appeal No. 2017-1135 (Fed. Cir. Oct. 9, 2018) -
In one of two Section 101 cases this week, the Federal Circuit affirmed-in-part, reversed-in-part, and...more
10/16/2018
/ Abstract Ideas ,
Appeals ,
Inter Partes Review (IPR) Proceeding ,
Judgment on the Pleadings ,
Obviousness ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Prior Art ,
Remand ,
Reversal ,
Section 101 ,
Summary Judgment
Praxair Distribution, Inc. v. Mallinckrodt Hospital Products IP Ltd., Appeal Nos. 2016-2616, -2656 (Fed. Cir. May 16, 2018) -
In an appeal from a inter partes review, the Federal Circuit reviewed a PTAB obviousness...more
5/22/2018
/ Burden of Proof ,
Claim Construction ,
Claim Limitations ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Personal Jurisdiction ,
Pharmaceutical Patents ,
Prior Art ,
Section 101 ,
Venue ,
Writ of Mandamus
Berkheimer v. HP Inc., Appeal No. 2017-1437 (Fed. Cir. Feb. 8, 2018) -
In Berkheimer v. HP Inc., the Federal Circuit reviewed the District Court’s summary judgment finding that certain claims of a patent were invalid as...more
2/13/2018
/ AbbVie ,
Abstract Ideas ,
Antitrust Violations ,
Appeals ,
CLS Bank v Alice Corp ,
Contract Disputes ,
Contract Interpretation ,
Declaratory Judgments ,
Discovery Violations ,
Expert Testimony ,
Fraud ,
Hatch-Waxman ,
Hospira ,
Indefiniteness ,
Inter Partes Review (IPR) Proceeding ,
Inventions ,
Jurisdiction ,
License Agreements ,
Licensees ,
Merck ,
Misrepresentation ,
Motivation to Combine ,
Motor Vehicles ,
Nonobvious ,
Obviousness ,
On-Sale Bar ,
Patent Applications ,
Patent Examinations ,
Patent Infringement ,
Patent Litigation ,
Patent Ownership ,
Patent Term Adjustment ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Preliminary Injunctions ,
Prior Art ,
Sales & Distribution Agreements ,
Section 101 ,
Substantial Evidence ,
Summary Judgment ,
Walker Process Claims ,
Wrongful Termination